Literature DB >> 22652451

Mixed lineage kinase 3 is required for matrix metalloproteinase expression and invasion in ovarian cancer cells.

Yu Zhan1, Widian F Abi Saab, Nidhi Modi, Amanda M Stewart, Jinsong Liu, Deborah N Chadee.   

Abstract

Mixed lineage kinase 3 (MLK3) is a mitogen-activated protein kinase kinase kinase (MAP3K) that activates MAPK signaling pathways and regulates cellular responses such as proliferation, migration and apoptosis. Here we report high levels of total and phospho-MLK3 in ovarian cancer cell lines in comparison to immortalized nontumorigenic ovarian epithelial cell lines. Using small interfering RNA (siRNA)-mediated gene silencing, we determined that MLK3 is required for the invasion of SKOV3 and HEY1B ovarian cancer cells. Furthermore, mlk3 silencing substantially reduced matrix metalloproteinase (MMP)-1, -2, -9 and -12 gene expression and MMP-2 and -9 activities in SKOV3 and HEY1B ovarian cancer cells. MMP-1, -2, -9 and-12 expression, and MLK3-induced activation of MMP-2 and MMP-9 requires both extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) activities. In addition, inhibition of activator protein-1 (AP-1) reduced MMP-1, MMP-9 and MMP-12 gene expression. Collectively, these findings establish MLK3 as an important regulator of MMP expression and invasion in ovarian cancer cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652451      PMCID: PMC3389280          DOI: 10.1016/j.yexcr.2012.05.002

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  36 in total

1.  Constitutive JNK activation in NIH 3T3 fibroblasts induces a partially transformed phenotype.

Authors:  Ulrike E E Rennefahrt; Bertram Illert; Eugen Kerkhoff; Jakob Troppmair; Ulf R Rapp
Journal:  J Biol Chem       Date:  2002-05-30       Impact factor: 5.157

2.  Activation of the Drosophila MLK by ceramide reveals TNF-alpha and ceramide as agonists of mammalian MLK3.

Authors:  Pradeep Sathyanarayana; Manoj K Barthwal; Chanakya N Kundu; Mary Ellen Lane; Andreas Bergmann; Guri Tzivion; Ajay Rana
Journal:  Mol Cell       Date:  2002-12       Impact factor: 17.970

3.  Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes.

Authors:  Marta Toth; Irina Chvyrkova; M Margarida Bernardo; Sonia Hernandez-Barrantes; Rafael Fridman
Journal:  Biochem Biophys Res Commun       Date:  2003-08-22       Impact factor: 3.575

4.  Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.

Authors:  B Schmalfeldt; D Prechtel; K Härting; K Späthe; S Rutke; E Konik; R Fridman; U Berger; M Schmitt; W Kuhn; E Lengyel
Journal:  Clin Cancer Res       Date:  2001-08       Impact factor: 12.531

5.  MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation.

Authors:  Deborah N Chadee; John M Kyriakis
Journal:  Nat Cell Biol       Date:  2004-07-18       Impact factor: 28.824

6.  Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation.

Authors:  Rosemary Steinmetz; Heather A Wagoner; Pingyu Zeng; Jessica R Hammond; Tamara S Hannon; Justin L Meyers; Ora H Pescovitz
Journal:  Mol Endocrinol       Date:  2004-07-08

Review 7.  Mixed-lineage kinase control of JNK and p38 MAPK pathways.

Authors:  Kathleen A Gallo; Gary L Johnson
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

8.  In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.

Authors:  Nathalie L G Sieben; Patricia Macropoulos; Guido M J M Roemen; Sandra M Kolkman-Uljee; Gert Jan Fleuren; Rifat Houmadi; Tim Diss; Bretta Warren; Mudher Al Adnani; Anton P M De Goeij; Thomas Krausz; Adrienne M Flanagan
Journal:  J Pathol       Date:  2004-03       Impact factor: 7.996

9.  A genetically defined model for human ovarian cancer.

Authors:  Jinsong Liu; Gong Yang; Jennifer A Thompson-Lanza; Armand Glassman; Kimberly Hayes; Andrea Patterson; Rebecca T Marquez; Nelly Auersperg; Yinhua Yu; William C Hahn; Gordon B Mills; Robert C Bast
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

10.  Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene.

Authors:  J Schütte; J D Minna; M J Birrer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more
  25 in total

1.  Osmotic and heat stress-dependent regulation of MLK4β and MLK3 by the CHIP E3 ligase in ovarian cancer cells.

Authors:  Natalya A Blessing; Srimathi Kasturirangan; Evan M Zink; April L Schroyer; Deborah N Chadee
Journal:  Cell Signal       Date:  2017-07-28       Impact factor: 4.315

Review 2.  Association between MMP-12-82A/G polymorphism and cancer risk: a meta-analysis.

Authors:  Luliang Liu; Jinhuan Sun; Guolin Li; Boyu Gu; Xiaolong Wang; Huirong Chi; Fulin Guo
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Nicotine inhibits MAPK signaling and spheroid invasion in ovarian cancer cells.

Authors:  Sarah J Harmych; Jay Kumar; Mesa E Bouni; Deborah N Chadee
Journal:  Exp Cell Res       Date:  2020-07-07       Impact factor: 3.905

4.  Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma.

Authors:  Caroline I Schnegg; Moon Hee Yang; Subrata K Ghosh; Mei-Yu Hsu
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

5.  BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells.

Authors:  Yan-jun Zhang; Lichun Wei; Mei Liu; Jie Li; Yi-qiong Zheng; Ying Gao; Xi-ru Li
Journal:  Tumour Biol       Date:  2013-02-19

6.  Domain specificity of MAP3K family members, MLK and Tak1, for JNK signaling in Drosophila.

Authors:  Beth Stronach; Ashley L Lennox; Rebecca A Garlena
Journal:  Genetics       Date:  2014-01-15       Impact factor: 4.562

Review 7.  Mixed Lineage Kinase-c-Jun N-Terminal Kinase Axis: A Potential Therapeutic Target in Cancer.

Authors:  Ajay Rana; Basabi Rana; Rajakishore Mishra; Gautam Sondarva; Velusamy Rangasamy; Subhasis Das; Navin Viswakarma; Anumantha Kanthasamy
Journal:  Genes Cancer       Date:  2013-09

8.  Decrement of miR-199a-5p contributes to the tumorigenesis of bladder urothelial carcinoma by regulating MLK3/NF-κB pathway.

Authors:  Tao Song; Xu Zhang; Guoqiang Yang; Yong Song; Wei Cai
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

9.  The E3 ligase CHIP mediates ubiquitination and degradation of mixed-lineage kinase 3.

Authors:  Natalya A Blessing; April L Brockman; Deborah N Chadee
Journal:  Mol Cell Biol       Date:  2014-06-09       Impact factor: 4.272

10.  LATS1 Regulates Mixed-Lineage Kinase 3 (MLK3) Subcellular Localization and MLK3-Mediated Invasion in Ovarian Epithelial Cells.

Authors:  Srimathi Kasturirangan; Batool Mehdi; Deborah N Chadee
Journal:  Mol Cell Biol       Date:  2021-06-23       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.